Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.
Werchau N, Kotter B, Criado-Moronati E, Gosselink A, Cordes N, Lock D, Lennartz S, Kolbe C, Winter N, Teppert K, Engert F, Webster B, Mittelstaet J, Schaefer D, Mallmann P, Mallmann MR, Ratiu D, Assenmacher M, Schaser T, von Bergwelt-Baildon M, Abramowski P, Kaiser AD. Werchau N, et al. Among authors: lennartz s. Oncoimmunology. 2022 Nov 11;11(1):2140534. doi: 10.1080/2162402X.2022.2140534. eCollection 2022. Oncoimmunology. 2022. PMID: 36387056 Free PMC article.
Automated generation of gene-edited CAR T cells at clinical scale.
Alzubi J, Lock D, Rhiel M, Schmitz S, Wild S, Mussolino C, Hildenbeutel M, Brandes C, Rositzka J, Lennartz S, Haas SA, Chmielewski KO, Schaser T, Kaiser A, Cathomen T, Cornu TI. Alzubi J, et al. Among authors: lennartz s. Mol Ther Methods Clin Dev. 2020 Dec 25;20:379-388. doi: 10.1016/j.omtm.2020.12.008. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2020. PMID: 33575430 Free PMC article.
Automated, scaled, transposon-based production of CAR T cells.
Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, Karasakalidou-Seidt R, Lukic T, Schmeer M, Schleef M, Werchau N, Eyrich M, Assenmacher M, Kaiser A, Prommersberger S, Schaser T, Hudecek M. Lock D, et al. Among authors: lennartz s. J Immunother Cancer. 2022 Sep;10(9):e005189. doi: 10.1136/jitc-2022-005189. J Immunother Cancer. 2022. PMID: 36096530 Free PMC article.
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
Teppert K, Winter N, Herbel V, Brandes C, Lennartz S, Engert F, Kaiser A, Schaser T, Lock D. Teppert K, et al. Among authors: lennartz s. Front Immunol. 2023 Oct 11;14:1178060. doi: 10.3389/fimmu.2023.1178060. eCollection 2023. Front Immunol. 2023. PMID: 37901209 Free PMC article.
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life.
Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, Askari-Motlagh D, Berg E, Feyerabend E, Kazmierczak P, Jokisch F, Becker A, Stief CG, Kretschmer A. Westhofen T, et al. Among authors: lennartz s. World J Urol. 2024 Oct 20;42(1):585. doi: 10.1007/s00345-024-05298-2. World J Urol. 2024. PMID: 39427278 Free PMC article.
Seeing the primary tumor because of all the trees: Cancer type prediction on low-dimensional data.
Gehrmann J, Soenarto DJ, Hidayat K, Beyer M, Quakulinski L, Alkarkoukly S, Berressem S, Gundert A, Butler M, Grönke A, Lennartz S, Persigehl T, Zander T, Beyan O. Gehrmann J, et al. Among authors: lennartz s. Front Med (Lausanne). 2024 Aug 27;11:1396459. doi: 10.3389/fmed.2024.1396459. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39257886 Free PMC article.
142 results